Drug Response-Related DNA Methylation Changes in Schizophrenia, Bipolar Disorder, and Major Depressive Disorder

Pharmacotherapy is the most common treatment for schizophrenia (SCZ), bipolar disorder (BD), and major depressive disorder (MDD). Pharmacogenetic studies have achieved results with limited clinical utility. DNA methylation (DNAm), an epigenetic modification, has been proposed to be involved in both...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Jiaqi, Li, Miao, Wang, Xueying, He, Yuwen, Xia, Yan, Sweeney, John A., Kopp, Richard F., Liu, Chunyu, Chen, Chao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8155631/
https://www.ncbi.nlm.nih.gov/pubmed/34054421
http://dx.doi.org/10.3389/fnins.2021.674273

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8155631/
https://www.ncbi.nlm.nih.gov/pubmed/34054421
http://dx.doi.org/10.3389/fnins.2021.674273

Ejemplares similares